The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

A Breast Most cancers Survivor’s First Brush with Pores and skin Most cancers

Self-checks for pores and skin most cancers, in addition to common check-ups with a dermatologist, are necessary for breast most cancers survivors....

Caregivers Typically Overlook Their Personal Well being Whereas Supporting Sufferers

Dr. Tracy Proverbs-Singh, a gastrointestinal oncologist at John Theurer Most cancers Heart, mentioned how caregivers usually overlook their very own well being...

Most Sufferers With HER2+ Breast Most cancers Miss Normal Remedy, Research Exhibits

Cleveland Clinic researchers have discovered that just about two-thirds of sufferers with HER2-positive metastatic breast most cancers didn't obtain the guideline-recommended normal...

Knowledgeable insights into Biomarker-Pushed Care and Rising Targets in GI Most cancers

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of drugs on the Cleveland Clinic...

Research Identifies Why Some Breast Cancers Resist Enhertu Remedy

Researchers have introduced data revealing how sufferers with metastatic breast most cancers develop resistance to the therapy Enhertu (trastuzumab deruxtecan, T-DXd) in...

Hot Topics